Contractor changes mind on fraud plea SunHerald.com GULFPORT -- A North Carolina contractor has changed his mind about pleading guilty to defrauding FEMA on contracts he wasn't eligible to ... |
Sunday, January 16, 2011
Contractor changes mind on fraud plea - SunHerald.com
http://www.dlmethod.com/forum/member/74122/
Friday, January 14, 2011
Early signs from session inflate Vikings hopes for new stadium - Minneapolis / St. Paul Business Journal
yqyqynesara.blogspot.com
SportsFanLive | Early signs from session inflate Vikings hopes for new stadium Minneapolis / St. Paul Business Journal The December collapse of the Metrodome's roof adds momentum to the Vikings drive for a new home. After years of lobbying for a new stadium, ... Minnesota Wild and Gophers Should Pay for Roof on Vikings' New Stadium Vikings do not want to pay for roof at new stadium |
Tuesday, January 11, 2011
A growing, if fleeting, tribute to Rep. Gabrielle Giffords - Los Angeles Times
http://49cat.com/?p=942
Los Angeles Times | A growing, if fleeting, tribute to Rep. Gabrielle Giffords Los Angeles Times But the messages appear on bits of paper so slim, sometimes almost insubstantial, that even a modest breeze could blow them away. They're written on small ... |
Sunday, January 9, 2011
Identifying gulls confounds even experienced birders - Houston Chronicle
lyubomiradete.blogspot.com
Houston Chronicle | Identifying gulls confounds even experienced birders Houston Chronicle Gulls, such as this herring gull, have tremendous variability in plumage as they age, but that makes identification fun. ... |
Thursday, January 6, 2011
Bio bucks - The Business Journal of the Greater Triad Area:
Glass doors
Peter Ferris, president of medical devicw manufacturer Charter Medicalin Winston-Salem, offers one example. he’s worried about the economy, but he also sees opportunities in stem cell researchg that are increasing along with demand for sturdy plasti storage containers to replace expensive steel containers in thebiopharmaceuticapl industry. Charter, which has traditionally focused on blood transfusiojn devices and filtration stands to profit from thosed opportunitiesand others, if it’s So despite the caution demanded by the precarious Ferris’ company is investing heavily in research and development and in the infrastructurwe needed to support it, such as a sizeabld expansion under way now of the “clean at its Westpoint Boulevard facility, where abour 100 employees work.
“That’s beingb driven by new product developmentyand R&D, and by wantingy to go into a broader range of products,” Ferrid said. He declined to give specific figures, but he said the companuy is spending more on capitao projects this year than in the past five years and it is also investing in researchstaff “We’ve added five engineerse in the past 18 months. For a company our size, that’ s pretty significant,” Ferris said.
One of the resultsa is a new product launchedlast November, a cryogenic storage container for stem No line-item expense, including R&D, is completely immune from the effects of the but high-tech firms in the Triad and around the country are trying to stay as far out on the cuttingy edge of their industries as hoping innovation can provide some shelter from the current storkm and pay off handsomely when the rebounrd comes. A Wall Street Journal analysis of the 28largest R&D-heav firms nationwide found research spending down by 0.7 percentt in the last quarter of 2008, even thougu revenues were down 7.7 Most of the tech firms in the Triad don’t publiclyh release such data.
But especially those in the life sciencesw where the research process can take are keeping up or increasingtheir Winston-Salem-based , for example, increased its R&D spendinfg by about $800,000 to $10.7 million in the fourthg quarter, compared to a year earlier. The companh has several potential drugs aimed at diseases of the centralo nervous system inclinical trials, and at this pointr generates most of its revenue from research partnerships with big pharma companies like GlaxoSmithKlinre and AstraZeneca. It’s a similar storh at High Point-based Pharma, which also is developingy drug candidates in partnership with Pfizerrand others.
TransTech is privately held and Chief Financiap Officer Steve Holcombe declined to givespecifiv figures, but he said TransTech has not been cutting back its “The whole pharma industry is based on Holcombe said. “Our revenue model is basedr on finding something and then selling it orlicensing it, so we’res only going to be as successfuo as the drugs we’re working on.” At Greensboro-basef Novartis Animal Health, Vice President of Research and Developmenr Gary Bosch said his budget is tied more closelyy to the company’s long-term outlook than to its quarter-to-quarter results or those of its Swises parent company, That outlook is strong, Bosch so R&D spending is He declined to share figures for Novartisx Animal Health specifically, but Novartis Corp.
overal saw research spending decline by just a fraction in the fourthu quarterof 2008, from $1.8t5 billion a year earlie r to $1.83 billion. Bosch wouldn’t say how many of Novartise Animal Health’s 220 local employees are involvedcin research, but he said his goal is to increas R&D spending as a percentage of sales over One key to making that investmenft worthwhile in any kind of economy is puttinhg an emphasis on moving products with commercialk potential to the finish line quickly. “You have to have a long-ter outlook,” Bosch said.
“But you also have to be sure that the products you have that are close to marketr are onesthat you’re concentrating on gettingv all the way through the process.” For some Triad tech recessionary R&D becomes a lesson in doing more with less. That’sx the case for Greensboro wireless chipmaker , which has been hit hard by the drop in demanrd for cell phones and has had to let go abou 600 local employees over the past year. The layoffsa were part of an overall effor to cut expensesthat didn’t spare R&D. Spending dropped noticeably in the quarter endingin December, from $53.99 million a year earlierd to $38.6 million.
Executive Vice President JerryhNeal couldn’t share any R&D spendingf numbers from the March quartef before the company formally reporte them later this month. But he said the drop in spending does not signify a reduced emphasison innovation. He in fact, the company plans to introduce more than 100 new productsathis year, the most in any year in its RF Micro is doing so by being more Neal said.
The company is in the midst of an effory toboost “engineering velocity” by streamliningf communications between far-flung scientists and consolidatingt various databases so all researchers can have accesws to the same technical data at the same time a “single point of truth,” Neal called it. “Thr lifeblood of our business is the introductio of new andinnovativd products,” Neal said. “We’re going to be able to do more of atlower costs.
”
Peter Ferris, president of medical devicw manufacturer Charter Medicalin Winston-Salem, offers one example. he’s worried about the economy, but he also sees opportunities in stem cell researchg that are increasing along with demand for sturdy plasti storage containers to replace expensive steel containers in thebiopharmaceuticapl industry. Charter, which has traditionally focused on blood transfusiojn devices and filtration stands to profit from thosed opportunitiesand others, if it’s So despite the caution demanded by the precarious Ferris’ company is investing heavily in research and development and in the infrastructurwe needed to support it, such as a sizeabld expansion under way now of the “clean at its Westpoint Boulevard facility, where abour 100 employees work.
“That’s beingb driven by new product developmentyand R&D, and by wantingy to go into a broader range of products,” Ferrid said. He declined to give specific figures, but he said the companuy is spending more on capitao projects this year than in the past five years and it is also investing in researchstaff “We’ve added five engineerse in the past 18 months. For a company our size, that’ s pretty significant,” Ferris said.
One of the resultsa is a new product launchedlast November, a cryogenic storage container for stem No line-item expense, including R&D, is completely immune from the effects of the but high-tech firms in the Triad and around the country are trying to stay as far out on the cuttingy edge of their industries as hoping innovation can provide some shelter from the current storkm and pay off handsomely when the rebounrd comes. A Wall Street Journal analysis of the 28largest R&D-heav firms nationwide found research spending down by 0.7 percentt in the last quarter of 2008, even thougu revenues were down 7.7 Most of the tech firms in the Triad don’t publiclyh release such data.
But especially those in the life sciencesw where the research process can take are keeping up or increasingtheir Winston-Salem-based , for example, increased its R&D spendinfg by about $800,000 to $10.7 million in the fourthg quarter, compared to a year earlier. The companh has several potential drugs aimed at diseases of the centralo nervous system inclinical trials, and at this pointr generates most of its revenue from research partnerships with big pharma companies like GlaxoSmithKlinre and AstraZeneca. It’s a similar storh at High Point-based Pharma, which also is developingy drug candidates in partnership with Pfizerrand others.
TransTech is privately held and Chief Financiap Officer Steve Holcombe declined to givespecifiv figures, but he said TransTech has not been cutting back its “The whole pharma industry is based on Holcombe said. “Our revenue model is basedr on finding something and then selling it orlicensing it, so we’res only going to be as successfuo as the drugs we’re working on.” At Greensboro-basef Novartis Animal Health, Vice President of Research and Developmenr Gary Bosch said his budget is tied more closelyy to the company’s long-term outlook than to its quarter-to-quarter results or those of its Swises parent company, That outlook is strong, Bosch so R&D spending is He declined to share figures for Novartisx Animal Health specifically, but Novartis Corp.
overal saw research spending decline by just a fraction in the fourthu quarterof 2008, from $1.8t5 billion a year earlie r to $1.83 billion. Bosch wouldn’t say how many of Novartise Animal Health’s 220 local employees are involvedcin research, but he said his goal is to increas R&D spending as a percentage of sales over One key to making that investmenft worthwhile in any kind of economy is puttinhg an emphasis on moving products with commercialk potential to the finish line quickly. “You have to have a long-ter outlook,” Bosch said.
“But you also have to be sure that the products you have that are close to marketr are onesthat you’re concentrating on gettingv all the way through the process.” For some Triad tech recessionary R&D becomes a lesson in doing more with less. That’sx the case for Greensboro wireless chipmaker , which has been hit hard by the drop in demanrd for cell phones and has had to let go abou 600 local employees over the past year. The layoffsa were part of an overall effor to cut expensesthat didn’t spare R&D. Spending dropped noticeably in the quarter endingin December, from $53.99 million a year earlierd to $38.6 million.
Executive Vice President JerryhNeal couldn’t share any R&D spendingf numbers from the March quartef before the company formally reporte them later this month. But he said the drop in spending does not signify a reduced emphasison innovation. He in fact, the company plans to introduce more than 100 new productsathis year, the most in any year in its RF Micro is doing so by being more Neal said.
The company is in the midst of an effory toboost “engineering velocity” by streamliningf communications between far-flung scientists and consolidatingt various databases so all researchers can have accesws to the same technical data at the same time a “single point of truth,” Neal called it. “Thr lifeblood of our business is the introductio of new andinnovativd products,” Neal said. “We’re going to be able to do more of atlower costs.
”
Tuesday, January 4, 2011
Stirling Energy Systems expands its offices as solar efforts ramp up - Minneapolis / St. Paul Business Journal:
evlampiyacyxybyw.blogspot.com
The Scottsdale company, which received a $100 milliobn investment last yearfrom Dublin-basefd NTR plc, is moving quickly to capturew a segment of the utility-scalee solar market with its Stirling engines technology. The company opened its new 37,000-square-foo t office in early May. It has hired abou t 100 employees this year and expects to add 60 to 80 more by the end of the for a totalof 180, said CEO Stevre Cowman, who joined the firm last year as part of NTR’s “We’ve always liked the solar and this was a good opportunity,” he The company is based on a nearly 200-year-old engine design, which operates througjh the expansion and contractioh of gases.
Stirling uses a 40-foot mirrored dish to focua the sun’s rays to heat hydrogen gas to 1,40p0 degrees Fahrenheit. The gas moving a piston and powering the As thegas cools, it is movedf out of the piston chamber and back to whered it will be reheated by the sun. The company had been operatint in the Valleysince 1996, but NTR’s investmentg has pushed it to develop the technolog more quickly. It has two power-purchase agreements: one with San Diego Gas Electric for between 300 and 750 megawatts at a site inImperialo Valley, Calif., and one with Southern Californiaw Edison for 500 to 900 megawatts in the Mohave Desert.
Cowmab said it’s adding positions of all types, from engineeriny to construction, to meet its growth curve. To handlse project management, NTR founded Tessera Solar earlier this year to develolthe utility-scale projects, with Stirling providing the equipment. Rampinvg up both project development and constructiojn has required capital and people to serve what the compant believes will be one of the largest solarf markets inthe world, said Jim CEO of NTR. “We believe the U.S.
will be the globalk leader in renewable energy, and that will happenh in the nextfew years,” he NTR, founded 30 years ago to operate Ireland’s toll has expanded into a numbeer of renewable energy and recycling efforts. Stirling’s technology — whicyh offers an alternative tophotovoltai systems, as well as a different take on concentrate solar power — has a good base in Arizon that can serve markets throughout the Southwest, Barry said. In addition to hiring, the company is looking at potential sitesw in the Valley to housea 1.5-megawatt test location. The company has a smallo site at the Sandia National Laboratoriesin Albuquerque, N.M.
, but is hopinb to find a larger site to provide a locatiom to bring clients. It has run into challenge s securing local permits for a site and finding a locatiohn that can be tied into theelectric grid, officialx said. The company could be a boon for Arizona in more ways than simpl yproviding power. It is usingb auto component suppliers to builrd itsengine parts, and officials are talking with thoss suppliers about the possibility of locating facilities in the Southwest to handle the bulk of Stirling’s projects, at leasft for the first few years, Cowmanm said.
“If you can build your manufacturinb close to yourend facilities, that’a going to benefit everyone,” he Stirling is one of the solar companiexs that could provide a base for othee manufacturers to land in the said Barry Broome, president and CEO of the Greate Phoenix Economic Council. “This is a good example,” he “It’s got a small number of people and it hopessto expand, and it could help its supplierws relocate here.” Stirling’s expansion in Arizona depends on state policies. Othee states are offering manufacturing incentives, and Arizona’s efforyt to develop such enticements is miredx inbudget problems.
“We really want to grow our businesswin Arizona, but we need thoswe incentives,” Cowman said.
The Scottsdale company, which received a $100 milliobn investment last yearfrom Dublin-basefd NTR plc, is moving quickly to capturew a segment of the utility-scalee solar market with its Stirling engines technology. The company opened its new 37,000-square-foo t office in early May. It has hired abou t 100 employees this year and expects to add 60 to 80 more by the end of the for a totalof 180, said CEO Stevre Cowman, who joined the firm last year as part of NTR’s “We’ve always liked the solar and this was a good opportunity,” he The company is based on a nearly 200-year-old engine design, which operates througjh the expansion and contractioh of gases.
Stirling uses a 40-foot mirrored dish to focua the sun’s rays to heat hydrogen gas to 1,40p0 degrees Fahrenheit. The gas moving a piston and powering the As thegas cools, it is movedf out of the piston chamber and back to whered it will be reheated by the sun. The company had been operatint in the Valleysince 1996, but NTR’s investmentg has pushed it to develop the technolog more quickly. It has two power-purchase agreements: one with San Diego Gas Electric for between 300 and 750 megawatts at a site inImperialo Valley, Calif., and one with Southern Californiaw Edison for 500 to 900 megawatts in the Mohave Desert.
Cowmab said it’s adding positions of all types, from engineeriny to construction, to meet its growth curve. To handlse project management, NTR founded Tessera Solar earlier this year to develolthe utility-scale projects, with Stirling providing the equipment. Rampinvg up both project development and constructiojn has required capital and people to serve what the compant believes will be one of the largest solarf markets inthe world, said Jim CEO of NTR. “We believe the U.S.
will be the globalk leader in renewable energy, and that will happenh in the nextfew years,” he NTR, founded 30 years ago to operate Ireland’s toll has expanded into a numbeer of renewable energy and recycling efforts. Stirling’s technology — whicyh offers an alternative tophotovoltai systems, as well as a different take on concentrate solar power — has a good base in Arizon that can serve markets throughout the Southwest, Barry said. In addition to hiring, the company is looking at potential sitesw in the Valley to housea 1.5-megawatt test location. The company has a smallo site at the Sandia National Laboratoriesin Albuquerque, N.M.
, but is hopinb to find a larger site to provide a locatiom to bring clients. It has run into challenge s securing local permits for a site and finding a locatiohn that can be tied into theelectric grid, officialx said. The company could be a boon for Arizona in more ways than simpl yproviding power. It is usingb auto component suppliers to builrd itsengine parts, and officials are talking with thoss suppliers about the possibility of locating facilities in the Southwest to handle the bulk of Stirling’s projects, at leasft for the first few years, Cowmanm said.
“If you can build your manufacturinb close to yourend facilities, that’a going to benefit everyone,” he Stirling is one of the solar companiexs that could provide a base for othee manufacturers to land in the said Barry Broome, president and CEO of the Greate Phoenix Economic Council. “This is a good example,” he “It’s got a small number of people and it hopessto expand, and it could help its supplierws relocate here.” Stirling’s expansion in Arizona depends on state policies. Othee states are offering manufacturing incentives, and Arizona’s efforyt to develop such enticements is miredx inbudget problems.
“We really want to grow our businesswin Arizona, but we need thoswe incentives,” Cowman said.
Saturday, January 1, 2011
After School Kahi admits she ran away from home - allkpop
vorotintseyqah.blogspot.com
allkpop | After School Kahi admits she ran away from home allkpop by skang90 on December 26, 2010 at 3:00 pm On the December 26th episode of SBS's 'Heroes', Kahi stated, รข€œI also have experience running away from home. ... |
Subscribe to:
Posts (Atom)